Folyóiratcikkek tallózása szerző szerint "SE/AOK/K/Mellkassebészeti Klinika"

A találatok rendezése: Rendezés: Találatok:

  • Afatinib restrains K-RAS-driven lung tumorigenesis 
    Moll HP; Pranz K; Musteanu M; Grabner B; Hruschka N; Mohrherr J; Aigner P; Stiedl P; Brcic L; Laszlo, Viktoria; Schramek D; Moriggl R; Eferl R; Moldvay, Judit; Dezső, Katalin; Lopez-Casas PP; Stoiber D; Hidalgo M; Penninger J; Sibilia M; Győrffy, Balázs; Barbacid M; Döme, Balázs; Popper H; Casanova E (2018)
    On the basis of clinical trials using first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), it became a doctrine that V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (K-RAS) ...
  • A magyar tüdőtranszplantációs program indulása és első eredményei 
    Gieszer, Balázs; Radeczky, Péter; Ghimessy, Áron; Farkas, Attila; Csende, Kristóf; Bogyó, Levente; Fazekas, Levente; Kovács, Nóra; Madurka, Ildikó; Kocsis, Ákos; Agócs, László; Török, Klára; Bartók, Tibor; Dancs, Tamás; Schönauer, Nóra; Tóth, Krisztina; Szabó, József; Eszes, Noémi; Bohács, Anikó; Czebe, Krisztina; Csiszér, Eszter; Mihály, Sándor; Kovács, Lajos; Müller, Veronika; Elek, Jenő; Rényi-Vámos, Ferenc; Lang, György (2018)
  • Antibody-Mediated Rejection in a Multiple Lung Transplant Patient: A Case Report 
    Radeczky, Péter; Ghimessy, Áron; Farkas, Attila; Csende, Kristóf; Mészáros, László Tibor; Török, Klára; Fazekas, Levente; Agócs, László; Kocsis, Ákos; Bartók, T; Dancs, T; Tóth, KK; Schönauer, N; Bogyó, Levente Zoltán; Bohács, Anikó; Madurka, Iildikó Eszter; Elek, J; Döme, Balázs; Rényi-Vámos, Ferenc István; Lang, György; Gieszer, Balázs (2019)
  • Apelin promotes lymphangiogenesis and lymph node metastasis 
    Berta, Judit; Hoda MA; Laszlo, Viktoria; Rozsas A; Garay, Tamás; Torok S; Grusch M; Berger W; Paku, Sándor; Rényi-Vámos, Ferenc István; Masri B; Tóvári, József; Groger M; Klepetko W; Hegedűs, Balázs; Döme, Balázs (2014)
    Whereas the role of the G-protein-coupled APJ receptor and its ligand, apelin, in angiogenesis has been well documented, the ability of the apelin/APJ system to induce lymphangiogenesis and lymphatic metastasis has been ...
  • Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients 
    Rojko L; Reiniger, Lilla; Téglási, Vanda; Fábián, Katalin; Pipek, Orsolya Anna; Vágvölgyi, Attila; Agocs L; Fillinger J; Kajdacsi Z; Tímár, József; Döme, Balázs; Szállási, Zoltán; Moldvay, Judit (2018)
    OBJECTIVES: While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been extensively studied, the impact of standard platinum-based ...
  • Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma 
    Klikovits T; Stockhammer P; Laszlo V; Dong Y; Hoda MA; Ghanim B; Opitz I; Frauenfelder T; Nguyen-Kim TDL; Weder W; Berger W; Grusch M; Aigner C; Klepetko W; Döme, Balázs; Rényi-Vámos, Ferenc István; Oehler R; Hegedűs, Balázs (2017)
    Only limited information is available on the role of complement activation in malignant pleural mesothelioma (MPM). Thus, we investigated the circulating and tissue levels of the complement component 4d (C4d) in MPM. Plasma ...
  • Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases 
    Moldvay Judit; Fábián Katalin; Jäckel Márta; Németh Zsuzsanna; Bogos Krisztina; Furák József; Tiszlavicz László; Fillinger János; Döme Balázs; Schaff Zsuzsa (2017)
    The aim of the study was to investigate the correlation between claudin (CLDN) protein expression and clinicopathological parameters as well as survival in histological subtypes of non-small cell lung cancer. Archived ...
  • Distinct epidemiology and clinical consequence of classic versus rare EGFR mutations in lung adenocarcinoma. 
    Lohinai, Zoltán; Hoda MA; Fábián, Katalin; Ostoros, Gyula; Rásó, Erzsébet; Barbai, Tamás; Tímár, József; Kovalszky, Ilona; Cserepes, Tamás Mihály; Laszlo, Viktoria; Grusch M; Berger W; Klepetko W; Moldvay, Judit; Döme, Balázs; Hegedűs, Balázs (2015)
    INTRODUCTION:: While classic sensitizing mutations of epidermal growth factor receptor (EGFR) are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung adenocarcinoma, there are rare EGFR mutations ...
  • Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE) 
    Sárosi, Veronika; Losonczy, György; Francovszky E; Tolnay E; Török, Szilvia; Gálffy, Gabriella; Hegedűs, Balázs; Döme, Balázs; Ostoros, Gyula (2014)
    OBJECTIVES: Erlotinib is an epidermal growth factor receptor tyrosine-kinase inhibitor (EGFR-TKI), used for the treatment of non-small cell lung cancer. As the clinical significance of KRAS mutational status has not yet ...
  • Epigenetic down-regulation of integrin alpha7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma 
    Laszlo V; Hoda MA; Garay, Tamás; Pirker C; Ghanim B; Klikovits T; Dong YW; Rózsás, Anita; Kenessey, István; Szirtes, Ildikó; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zochbauer-Muller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Döme, Balázs; Hegedűs, Balázs (2015)
    Malignant pleural mesothelioma (MPM) is a devastating malignancy characterized by invasive growth and rapid recurrence. The identification and inhibition of molecular components leading to this migratory and invasive ...
  • FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal 
    Schelch K; Wagner C; Hager S; Pirker C; Siess K; Döme, Balázs; Hegedűs, Balázs (2018)
    Malignant pleural mesothelioma (MPM), an aggressive malignancy affecting pleural surfaces, occurs in three main histological subtypes. The epithelioid and sarcomatoid subtypes are characterized by cuboid and fibroblastoid ...
  • Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy 
    Schelch K; Hoda MA; Klikovits T; Munzker J; Ghanim B; Wagner C; Garay, Tamás; Laszlo, Viktoria; Setinek U; Döme, Balázs; Filipits M; Pirker C; Heffeter P; Selzer E; Tóvári, József; Török, Szilvia; Kenessey, István; Holzmann K; Grasl-Kraupp B; Marian B; Klepetko W; Berger W; Hegedűs, Balázs; Grusch M (2014)
    RATIONALE: Malignant pleural mesothelioma is an aggressive malignancy characterized by frequent resistance to chemo- and radiotherapy, poor outcome, and limited therapeutic options. Fibroblast growth factors (FGFs) and ...
  • First 3 Years of the Hungarian Lung Transplantation Program 
    Gieszer, Balázs; Ghimessy, Áron; Radeczky, Péter; Farkas, Attila; Csende, Kristóf; Bogyó, Levente Zoltán; Fazekas, Levente; Kovács, Nóra; Madurka, Ildikó Eszter; Kocsis, Ákos; Agócs, László; Török, Klára; Bartók, Tibor; Dancs, Tamás; Schönauer, Nóra; Tóth, Kriszta; Eszes, Noémi; Bohács, Anikó; Czebe, Krisztina; Csiszér, Eszter; Mihály, Sándor; Kovács, Lajos; Müller, Veronika; Elek, Jenő; Rényi-Vámos, Ferenc; Lang, György (2019)
    In this article we summarize the results of the first 3 years after launching the Hungarian Lung Transplantation Program.The first lung transplant in Hungary was carried out on December 12, 2015, with the collaboration of ...
  • High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma 
    Hoda, M Alireza; Rózsás, Anita; Lang, Elisabeth; Klikovits, Thomas; Lohinai, Zoltán; Török , Szilvia; Berta, Judit; Mátyás, Bendek; Walter, Berger; Hegedűs, Balázs; Walter, Klepetko; Rényi-Vámos, Ferenc István; Michael, Grusch; Döme, Balázs; Viktória, László (2016)
    Activin A (ActA)/follistatin (FST) signaling has been shown to be deregulated in different tumor types including lung adenocarcinoma (LADC). Here, we report that serum ActA protein levels are significantly elevated in ...
  • JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression 
    Mohrherr, J; Haber, M; Breitenecker, K; Aigner, P; Moritsch, S; Voronin, V; Eferl, R; Moriggl, R; Stoiber, D; Győrffy, Balázs; Brcic, L; László, V; Döme, Balázs; Moldvay, Judit; Dezső, Katalin; Bilban, M; Popper, H; Moll, HP; Casanova, E (2019)
  • Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study 
    Ghanim B; Klikovits T; Hoda MA; Lang, György; Szirtes, Ildikó; Setinek U; Rozsas A; Rényi-Vámos, Ferenc István; Laszlo V; Grusch M; Filipits M; Scheed A; Jakopovic M; Samarzija M; Brcic L; Stancic-Rokotov D; Kern I; Rozman A; Dekan G; Klepetko W; Berger W; Glasz, Tibor; Döme, Balázs; Hegedűs, Balázs (2015)
    BACKGROUND: Estimating the prognosis in malignant pleural mesothelioma (MPM) remains challenging. Thus, the prognostic relevance of Ki67 was studied in MPM. METHODS: Ki67 index was determined in a test cohort of 187 cases ...
  • KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS-mutation and bone metastasis 
    Lohinai Zoltán; Klikovits Thomas; Moldvay Judit; Ostoros Gyula; Rásó Erzsébet; Tímár József; Fábián Katalin; Kovalszky Ilona; Kenessey István; Aigner C; Rényi-Vámos Ferenc István; Klepetko W; Döme Balázs; Hegedűs Balázs (2017)
  • Localization of sunitinib, its metabolites and its target receptors in tumour bearing mice: a MALDI mass spectrometry imaging study 
    Török, Szilvia; Vegvari A; Rezeli M; Fehniger TE; Tóvári, József; Paku, Sándor; Laszlo, Viktoria; Hegedűs, Balázs; Rózsás, Anita; Döme, Balázs; Marko-Varga G (2015)
    BACKGROUND AND PURPOSE: The clinical impact of antiangiogenic agents remains controversial. Therefore, elucidating the pharmacological properties of these compounds is a pivotal issue. EXPERIMENTAL APPROACH: In our study, ...
  • Mapping of the functional anatomy of lymphatic drainage to the axilla in early breast cancer: A cohort study of 933 cases 
    Dorogi, Bence; Bukovszky, Bence; Mátrai, Tamás; Sávolt, Ákos; Polgár, Csaba; Kelemen, Péter; Kovács, Tibor; Rényi-Vámos, Ferenc; Ivády, Gabriella; Kovács, Eszter; Téglás, Melinda; Kásler, Miklós; Mátrai, Zoltán (2019)
    The aims of this study were to investigate the correlation between lymphatic drainage and the sentinel lymph node (SLN) status of the subregions in the context of the clinic-pathological parameters of the tumour and the ...
  • Mechanism of tumour vascularisation in experimental lung metastases 
    Szabó, Vanessza; Bugyik, Edina; Dezső, Katalin; Ecker N; Nagy, Péter; Tímár, József; Tóvári, József; Laszlo, Viktoria; Bridgeman VL; Wan E; Frentzas S; Vermeulen PB; Reynolds AR; Döme, Balázs; Paku, Sándor (2015)
    The appearance of lung metastases is associated with poor outcome and the management of patients with secondary pulmonary tumours remains a clinical challenge. We examined the vascularisation process of lung metastasis in ...